Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Naomi Hayashi"'
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL) are two rare types of adrenal gland malignancies. Regarding hereditary tumors, some patients with ACC are associated with with Li-Fraumeni syndrome (LFS), and those wit
Externí odkaz:
https://doaj.org/article/2055a2c5625948b4838ef4eb08b10772
Autor:
Naomi Hayashi, Ippei Fukada, Akihiro Ohmoto, Masumi Yamazaki, Xiaofei Wang, Mari Hosonaga, Shunji Takahashi
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-8 (2022)
Abstract Performance status (PS) is widely used as an assessment of general condition in patients before performing comprehensive genomic profiling (CGP). However, PS scoring is dependent on each physician, and there is no objective and universal ind
Externí odkaz:
https://doaj.org/article/4ae4d7a8fe7b4a038f1d270beb1c2605
Autor:
Ippei Fukada, Seiichi Mori, Naomi Hayashi, Mari Hosonaga, Masumi Yamazaki, Xiaofei Wang, Saori Kawai, Lina Inagaki, Yukinori Ozaki, Kokoro Kobayashi, Fumikata Hara, Takayuki Kobayashi, Arisa Ueki, Tomo Osako, Akiko Tonooka, Kengo Takeuchi, Takayuki Ueno, Toshimi Takano, Shinji Ohno, Shunji Takahashi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Comprehensive cancer genomic profile (CGP) tests are being implemented under Japanese universal health insurance system. However, the clinical usefulness of CGP test for breast cancer patients has not been evaluated. Of the 310 patients who
Externí odkaz:
https://doaj.org/article/89eefc4b8f4f4335bd68ccdd4835a126
Autor:
Akihiro Ohmoto, Kenji Nakano, Naoki Fukuda, Xiaofei Wang, Tetsuya Urasaki, Naomi Hayashi, Hirotaka Suto, Shohei Udagawa, Ryosuke Oki, Yasuyoshi Sato, Mayu Yunokawa, Makiko Ono, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Junichi Tomomatsu, Shunji Takahashi
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Trabectedin is a therapeutic option for patients with advanced sarcoma. While a randomized trial demonstrated its prolonged progression-free survival (PFS), the reported PFS was 1 year). The ORR in the 49 evaluable patients was 8%, and the median PFS
Externí odkaz:
https://doaj.org/article/1ad98d3f83ec4a80b58fa31dacaacb84
Autor:
Akihiro Ohmoto, Naomi Hayashi, Ippei Fukada, Masumi Yamazaki, Mayu Yunokawa, Akiyoshi Kasuga, Eiji Shinozaki, Arisa Ueki, Akiko Tonooka, Kengo Takeuchi, Seiichi Mori, Kazuma Kiyotani, Shunji Takahashi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 33, Iss , Pp 100834- (2022)
Without a current standard of care, patients with rare malignancy are subjected to precision oncology with next-generation sequencing to identify a course of treatment. We sought to establish the clinical relevance of comprehensive genomic profiling
Externí odkaz:
https://doaj.org/article/b15faeccd1174bc69e85f8ec5bc47e4d
Autor:
Kaori Kitamura, Yumi Watanabe, Kazutoshi Nakamura, Chikako Takano, Naomi Hayashi, Hisami Sato, Toshiyuki Someya
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Beneficial effects of napping on cognition have been suggested in cross-sectional studies. This study aimed to clarify longitudinal associations between cognitive decline and sleep characteristics, particularly daytime napping, ov
Externí odkaz:
https://doaj.org/article/69fcb58e3fb84616855d4065e8128699
Autor:
Yasuyoshi Sato, Kenji Nakano, Xiaofei Wang, Naoki Fukuda, Tetsuya Urasaki, Akihiro Ohmoto, Naomi Hayashi, Mayu Yunokawa, Makiko Ono, Junichi Tomomatsu, Masanori Saito, Yusuke Minami, Keiko Hayakawa, Yuki Funauchi, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Shunji Takahashi
Publikováno v:
Cancers, Vol 13, Iss 24, p 6266 (2021)
Pazopanib with trabectedin and eribulin is widely used to treat soft-tissue sarcoma (STS). We have shown that baseline neutrophil-to-lymphocyte ratio (NLR) may predict the efficacy and patient prognosis of eribulin. Changes in NLR, but not baseline N
Externí odkaz:
https://doaj.org/article/cac8de16c1964cd4b568fc363dd45969
Autor:
Goro Nakayama, Kiyoshi Ishigure, Hiroyuki Yokoyama, Keisuke Uehara, Hiroshi Kojima, Akiharu Ishiyama, Naomi Hayashi, Nao Takano, Norifumi Hattori, Daisuke Kobayashi, Chie Tanaka, Masamichi Hayashi, Mitsuro Kanda, Suguru Yamada, Hiroyuki Sugimoto, Masahiko Koike, Michitaka Fujiwara, Tsutomu Fujii, Kenta Murotani, Yuichi Ando, Yasuhiro Kodera
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background The aim of this study was to evaluate the efficacy and safety of CapeOX plus bevacizumab with a planned oxaliplatin stop-and-go strategy in Japanese patients with metastatic colorectal cancer (mCRC). Methods Patients with untreate
Externí odkaz:
https://doaj.org/article/b1c96309c39243349d24d0197da497c6
Publikováno v:
Interação - Revista de Ensino, Pesquisa e Extensão. 24:60-76
Na cidade de São Paulo (SP), a construção civil de edifícios residenciais de múltiplos pavimentos intensificou-se na década de 1930, com estruturas de concreto armado e alvenaria de vedação. Esse processo construtivo se mantém majoritário n
Autor:
Yoichi Naito, Saori Mishima, Kiwamu Akagi, Naomi Hayashi, Akira Hirasawa, Tomoro Hishiki, Ataru Igarashi, Masafumi Ikeda, Shigenori Kadowaki, Hiroaki Kajiyama, Motohiro Kato, Hirotsugu Kenmotsu, Yasuhiro Kodera, Keigo Komine, Takafumi Koyama, Osamu Maeda, Mitsuru Miyachi, Hiroshi Nishihara, Hiroyuki Nishiyama, Shouichi Ohga, Wataru Okamoto, Eiji Oki, Shigeru Ono, Masashi Sanada, Ikuo Sekine, Tadao Takano, Kayoko Tao, Keita Terashima, Katsuya Tsuchihara, Yasushi Yatabe, Takayuki Yoshino, Eishi Baba
Publikováno v:
International Journal of Clinical Oncology.
Background Clinical trials have reported the efficacy of tropomyosin receptor kinase (TRK) inhibitors against neurotrophic receptor tyrosine kinase (NTRK) fusion gene-positive advanced solid tumors. The accumulated evidence of tumor-agnostic agent ha